コンテンツへスキップ
Merck

主要文書

すべての文書を表示

HCVD3MAG-67K

MILLIPLEX® Human Cardiovascular Disease Panel

Configurable Human CVD (Acute Phase) 10-Plex Panel 3

別名:

human CVD APP immunoassay panel, luminex human cardiovascular disease acute phase proteins multiplex assay, millipore human CVD acute phase proteins multiplex kit, CVD assay snapshot, CVD detection kit, CVD multiplex product sheet, cardiovascular biomarker listing, cardiovascular biomarker profile, human CVD assay overview, human cardiovascular panel summary, human inflammation product info, human vascular health research tool, vascular inflammation biomarker panel

ログインで組織・契約価格をご覧ください。

この商品について

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

製品名

MILLIPLEX® Human Cardiovascular Disease Panel,

Quality Segment

200

description

Configurable Human CVD (Acute Phase) 10-Plex Panel 3

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 102%
(Haptoglobin), accuracy: 109%
(AGP), accuracy: 113%
(Platelet Factor-4), accuracy: 117%
(Adipsin), standard curve range: 0.004-15 ng/mL
(L-Selectin & SAP), standard curve range: 0.012-50 ng/mL
(CRP), standard curve range: 0.037-150 ng/mL
(PF4), standard curve range: 0.061-250 ng/mL
(HPTGN), standard curve range: 0.098-400 ng/mL
(AGP & Adipsin), standard curve range: 0.244-1,000 ng/mL
(Fetuin A & vWF), standard curve range: 0.488-2,000 ng/mL
(A2M)

technique(s)

multiplexing: suitable

input

plasma
cell culture supernatant(s)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Cardiovascular disease is driven by a complex interplay of inflammation, coagulation, lipid metabolism, and immune response. This set of biomarkers—α-1-Acid Glycoprotein (AGP), α-2-Macroglobulin, Adipsin/Factor D, CRP, Fetuin A, Fibrinogen, Haptoglobin, sL-Selectin, Platelet Factor 4 (PF4)/CXCL4, and Serum Amyloid P (SAP)—captures key physiological processes associated with cardiovascular risk and progression. These analytes are involved in acute-phase response, vascular inflammation, platelet activation, and metabolic regulation, making them highly relevant for research in atherosclerosis, thrombosis, and systemic inflammation.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 10 analytes in human serum, plasma, or cell culture supernatants.

Analytes included: α-1-Acid Glycoprotein (AGP), α-2-Macroglobulin, Adipsin/Factor D, CRP, Fetuin A, Fibrinogen, Haptoglobin, sL-Selectin, Platelet Factor 4 (PF4)/CXCL4, Serum Amyloid P (SAP)

Note: Fibrinogen cannot be measured in serum samples.Assay Characteristics: Refer to assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Features:
  • Targets key biomarkers involved in cardiovascular inflammation, coagulation, and immune response
  • Includes 10 analytes relevant to vascular health, acute-phase response, and metabolic regulation
  • Multiplex format enables simultaneous detection from minimal sample volume
  • Compatible with human serum and plasma samples
  • Designed for research in cardiovascular disease, systemic inflammation, and metabolic disorders
Benefits:
  • Provides a comprehensive profile of cardiovascular and inflammatory biomarkers
  • Supports investigation of disease mechanisms in atherosclerosis, thrombosis, and vascular inflammation
  • Facilitates evaluation of therapeutic interventions targeting cardiovascular risk pathways
  • Enables high-throughput analysis with reduced sample and reagent use
  • Delivers reproducible, sensitive results for translational and clinical research

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Still not finding the right product?

Explore all of our products under MILLIPLEX® Human Cardiovascular Disease Panel

pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

保管分類

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする